Quick Answer
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. reported Diluted EPS of $1.82 per share (loss) for fiscal year 2025.
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.82 | -14.5% |
| 2024 | -$1.59 | -31.4% |
| 2023 | -$1.21 | +13.6% |
| 2022 | -$1.40 | -57.3% |
| 2021 | -$0.89 | -623.5% |
| 2020 | $0.17 | +130.9% |
| 2019 | -$0.55 | +27.6% |
| 2018 | -$0.76 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.13 | +40.9% | +7.1% |
| June 30, 2025 | -$0.14 | +78.1% | +90.3% |
| March 31, 2025 | -$1.44 | -396.6% | -554.5% |
| September 30, 2024 | -$0.22 | +15.4% | +65.6% |
| June 30, 2024 | -$0.64 | -128.6% | -120.7% |
| March 31, 2024 | -$0.29 | +19.4% | -11.5% |
| September 30, 2023 | -$0.26 | +23.5% | +7.1% |
| June 30, 2023 | -$0.28 | +12.5% | +22.2% |
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. showed a decrease of -14.5% in Diluted EPS compared to the prior fiscal year.
- Over the 2018–2025 period, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.’s diluted eps has declined by 139.5% (from $0.76 per share (loss) to $1.82 per share (loss)).
- The most recent figure is from PACIFIC BIOSCIENCES OF CALIFORNIA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: